By Patricia Van Arnum, Editorial Director, DCAT, [email protected] Whats next Glucagon-like peptide 1 (GLP-1) agonists, used to treat Type 2 diabetes and obesity, have been a success story in the industry, with Novo Nordisk riding a blockbuster wave with Ozempic/Wegovy (semaglutide), respectively for treating Type 2 diabetes and obesity, and Eli Lilly and Company also riding the wave with Mounjaro/Zepbound (tirzepatide), a dual-activating GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 medication, respectively for treating Type 2 diabetes and obesity
500ml bottle = 50 Servings Attention: The nutritional substances may vary slightly depending on flavor
Documentation Batch-specific composition and safety documentation
Serine metabolism orchestrates macrophage polarization by regulating the IGF1-p38 axis
Used together, they address the full spectrum of skin aging, giving you a complexion that looks both firm and luminous